Older adults with acute myeloid leukemia (AML) treated with hypomethylating agents (HMAs) have more time at home (TAH), ... A study examined the clinical use of ultra-deep next-generation sequencing measurable residual disease (NGS-MRD) before ... Researchers of a study sought to discern causes of treatment failure and early mortality in acute myeloid leukemia (AML) ... Researchers assessed the incidence and clinical outcomes of non-ischemic or dilated cardiomyopathies in LVAD patients ... In a meta-analysis presented at the 2022 American Society of Clinical Oncology Annual Meeting, researchers evaluated ... According to research presented at the 2022 American Society of Clinical Oncology Annual Meeting, graft-versus-host ... Hispanic patients had a significantly lower cumulative incidence of chronic graft-versus-host disease (GVHD) than ... The first-in-human, phase I clinical trial of ADI-001, an allogeneic gamma delta chimeric antigen receptor (CAR) T-cell ... A study presented at the 2022 American Society of Clinical Oncology Annual Meeting reported on results of a literature ... Patients who received an allogeneic hematopoietic stem cell transplant (HSCT) from matched related donors (MRD) or ... A study presented at the 2022 American Society of Clinical Oncology Annual Meeting found that an autologous CD7 chimeric ... A retrospective study found that partially mismatched blood or marrow transplantation with post-transplantation ... A study assessed autologous CD7 CAR-T therapy in refractory or relapsed r/r T-cell acute lymphoblastic leukemia/lymphoma ... Researchers reported updated results from a phase I trial of donor-derived CD7 chimeric antigen receptor (CAR) T cells ... Researchers assessed the Charlson comorbidity index (CCI) as a predictor of early mortality and overall survival (OS) in ... Researchers from a study presented at the 2022 American Society of Clinical Oncology Annual Meeting identified ... A recent analysis shows that shallow whole-genome sequencing (sWGS) is an accurate, convenient, and cost-effective ... Researchers conducted a study to discern clinical predictors for the development of venous thromboembolism (VTE) in ... The use of machine learning methods is a viable option for identifying patients with myelodysplastic syndrome (MDS), ... Chronic myelomonocytic leukemia (CMML) is a heterogenous blood cancer which exhibits features similar to ...